Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
30201
30202
30203
30204
30205
30206
30207
30208
30209
30210
30211
30212
30213
30214
30215
30216
30217
30218
30219
30220
30221
30222
30223
30224
30225
30226
30227
30228
30229
30230
30231
30232
30233
30234
30235
30236
30237
30238
30239
30240
30241
30242
30243
30244
30245
30246
30247
30248
30249
30250
30251
30252
30253
30254
30255
30256
30257
30258
30259
30260
30261
30262
30263
30264
30265
30266
30267
30268
30269
30270
30271
30272
30273
30274
30275
30276
30277
30278
30279
30280
30281
30282
30283
30284
30285
30286
30287
30288
30289
30290
30291
30292
30293
30294
30295
30296
30297
30298
30299
30300
30301
30302
30303
30304
30305
30306
30307
30308
30309
30310
30311
30312
30313
30314
30315
30316
30317
30318
30319
30320
30321
30322
30323
30324
30325
30326
30327
30328
30329
30330
30331
30332
30333
30334
30335
30336
30337
30338
30339
30340
30341
30342
30343
30344
30345
30346
30347
30348
30349
30350
30351
30352
30353
30354
30355
30356
30357
30358
30359
30360
30361
30362
30363
30364
30365
30366
30367
30368
30369
30370
30371
30372
30373
30374
30375
30376
30377
30378
30379
30380
30381
30382
30383
30384
30385
30386
30387
30388
30389
30390
30391
30392
30393
30394
30395
30396
30397
30398
30399
30400
| UnnamedSample_HQ_transcript/30398|m.9564 | UnnamedSample_HQ_transcript/30398 | Coverage 0.091 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/30398|m.9564 | UnnamedSample_HQ_transcript/30398 | Coverage 0.091 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/30398|m.9564 | UnnamedSample_HQ_transcript/30398 | Coverage 0.091 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/22607|m.7591 | UnnamedSample_HQ_transcript/22607 | Coverage 0.077 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/22607|m.7591 | UnnamedSample_HQ_transcript/22607 | Coverage 0.077 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/22607|m.7591 | UnnamedSample_HQ_transcript/22607 | Coverage 0.077 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/47740|m.13518 | UnnamedSample_HQ_transcript/47740 | Coverage 0.977 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/47740|m.13518 | UnnamedSample_HQ_transcript/47740 | Coverage 0.977 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/47740|m.13518 | UnnamedSample_HQ_transcript/47740 | Coverage 0.977 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/24070|m.7962 | UnnamedSample_HQ_transcript/24070 | Coverage 0.084 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/24070|m.7962 | UnnamedSample_HQ_transcript/24070 | Coverage 0.084 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/24070|m.7962 | UnnamedSample_HQ_transcript/24070 | Coverage 0.084 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/22306|m.7517 | UnnamedSample_HQ_transcript/22306 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/22306|m.7517 | UnnamedSample_HQ_transcript/22306 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/22306|m.7517 | UnnamedSample_HQ_transcript/22306 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/42023|m.12264 | UnnamedSample_HQ_transcript/42023 | Coverage 0.104 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/42023|m.12264 | UnnamedSample_HQ_transcript/42023 | Coverage 0.104 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/42023|m.12264 | UnnamedSample_HQ_transcript/42023 | Coverage 0.104 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/20467|m.6995 | UnnamedSample_HQ_transcript/20467 | Coverage 0.079 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/20467|m.6995 | UnnamedSample_HQ_transcript/20467 | Coverage 0.079 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/20467|m.6995 | UnnamedSample_HQ_transcript/20467 | Coverage 0.079 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/41274|m.12110 | UnnamedSample_HQ_transcript/41274 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/41274|m.12110 | UnnamedSample_HQ_transcript/41274 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/41274|m.12110 | UnnamedSample_HQ_transcript/41274 | Coverage 0.076 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/22464|m.7558 | UnnamedSample_HQ_transcript/22464 | Coverage 0.058 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/22464|m.7558 | UnnamedSample_HQ_transcript/22464 | Coverage 0.058 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/22464|m.7558 | UnnamedSample_HQ_transcript/22464 | Coverage 0.058 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/24603|m.8105 | UnnamedSample_HQ_transcript/24603 | Coverage 0.026 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/24603|m.8105 | UnnamedSample_HQ_transcript/24603 | Coverage 0.026 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/24603|m.8105 | UnnamedSample_HQ_transcript/24603 | Coverage 0.026 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/48437|m.13680 | UnnamedSample_HQ_transcript/48437 | Coverage 0.965 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/48437|m.13680 | UnnamedSample_HQ_transcript/48437 | Coverage 0.965 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/48437|m.13680 | UnnamedSample_HQ_transcript/48437 | Coverage 0.965 too low. | 9cc66f0cc837d376bcd3165242cb2a3a | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/32012|m.9952 | UnnamedSample_HQ_transcript/32012 | Coverage 0.940 too low. | 5c9b1e7154806fe988d455e0b88faf49 | 804 | Pfam | PF00009 | Elongation factor Tu GTP binding domain | 17 | 345 | 5.8E-66 | T | 22-09-2020 | IPR000795 | Transcription factor, GTP-binding domain |
| UnnamedSample_HQ_transcript/32012|m.9952 | UnnamedSample_HQ_transcript/32012 | Coverage 0.940 too low. | 5c9b1e7154806fe988d455e0b88faf49 | 804 | Pfam | PF14492 | Elongation Factor G, domain III | 489 | 550 | 1.5E-13 | T | 22-09-2020 | IPR041095 | Elongation Factor G, domain II |
| UnnamedSample_HQ_transcript/32012|m.9952 | UnnamedSample_HQ_transcript/32012 | Coverage 0.940 too low. | 5c9b1e7154806fe988d455e0b88faf49 | 804 | Pfam | PF00679 | Elongation factor G C-terminus | 725 | 785 | 5.8E-12 | T | 22-09-2020 | IPR000640 | Elongation factor EFG, domain V-like |
| UnnamedSample_HQ_transcript/32012|m.9952 | UnnamedSample_HQ_transcript/32012 | Coverage 0.940 too low. | 5c9b1e7154806fe988d455e0b88faf49 | 804 | Pfam | PF03144 | Elongation factor Tu domain 2 | 397 | 471 | 1.5E-10 | T | 22-09-2020 | IPR004161 | Translation elongation factor EFTu-like, domain 2 |
| UnnamedSample_HQ_transcript/32012|m.9952 | UnnamedSample_HQ_transcript/32012 | Coverage 0.940 too low. | 5c9b1e7154806fe988d455e0b88faf49 | 804 | Pfam | PF03764 | Elongation factor G, domain IV | 607 | 722 | 2.4E-29 | T | 22-09-2020 | IPR005517 | Translation elongation factor EFG/EF2, domain IV |
| UnnamedSample_HQ_transcript/12397|m.4619 | UnnamedSample_HQ_transcript/12397 | Coverage 0.830 too low. | 148f3dac4491f5acf73a6fc930971b7e | 1032 | Pfam | PF02213 | GYF domain | 609 | 654 | 1.0E-16 | T | 22-09-2020 | IPR003169 | GYF domain |
| UnnamedSample_HQ_transcript/45510|m.13037 | UnnamedSample_HQ_transcript/45510 | Identity 0.914 too low. | cc23afa6062b0c688de43d6b8d87d8fe | 228 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 1 | 86 | 2.2E-26 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/45510|m.13037 | UnnamedSample_HQ_transcript/45510 | Identity 0.914 too low. | cc23afa6062b0c688de43d6b8d87d8fe | 228 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 135 | 202 | 1.7E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/68625|m.17693 | UnnamedSample_HQ_transcript/68625 | Identity 0.486 too low. | 52ff23a33f9eb3346855330dca6764de | 447 | Pfam | PF03571 | Peptidase family M49 | 1 | 423 | 1.6E-194 | T | 22-09-2020 | IPR039461 | Peptidase family M49 |
| UnnamedSample_HQ_transcript/71713|m.18253 | UnnamedSample_HQ_transcript/71713 | Coverage 0.975 too low. | ede56e0d9e531c6a231a6342b29d9034 | 261 | Pfam | PF04190 | Protein of unknown function (DUF410) | 1 | 234 | 3.3E-63 | T | 22-09-2020 | IPR007317 | Golgi to ER traffic protein 4 |
| UnnamedSample_HQ_transcript/4670|m.2061 | UnnamedSample_HQ_transcript/4670 | Coverage 0.527 too low. | bfa52833a1b8c6cca650ac074d45e9ed | 529 | Pfam | PF00535 | Glycosyl transferase family 2 | 190 | 371 | 1.0E-30 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/59397|m.15926 | UnnamedSample_HQ_transcript/59397 | Coverage 0.323 too low. | 03efe7549260b2202d0f6e648e95425b | 168 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 78 | 140 | 5.9E-9 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/68201|m.17619 | UnnamedSample_HQ_transcript/68201 | Coverage 0.609 too low. | ced3a590029563fe0dd5803cf52520dc | 265 | Pfam | PF00005 | ABC transporter | 74 | 163 | 2.6E-11 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/85174|m.20521 | UnnamedSample_HQ_transcript/85174 | Coverage 0.943 too low. | d796636fa1d360b6285a13e2f50c700a | 257 | Pfam | PF00206 | Lyase | 22 | 171 | 1.5E-58 | T | 22-09-2020 | IPR022761 | Fumarate lyase, N-terminal |
| UnnamedSample_HQ_transcript/85174|m.20521 | UnnamedSample_HQ_transcript/85174 | Coverage 0.943 too low. | d796636fa1d360b6285a13e2f50c700a | 257 | Pfam | PF10415 | Fumarase C C-terminus | 237 | 257 | 1.2E-9 | T | 22-09-2020 | IPR018951 | Fumarase C, C-terminal |
| UnnamedSample_HQ_transcript/75730|m.18975 | UnnamedSample_HQ_transcript/75730 | Coverage 0.688 too low. | ec29e801b6684af144d6bea3a1c478d8 | 332 | Pfam | PF00651 | BTB/POZ domain | 161 | 266 | 1.3E-27 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/68893|m.17744 | UnnamedSample_HQ_transcript/68893 | Coverage 0.642 too low. | ec29e801b6684af144d6bea3a1c478d8 | 332 | Pfam | PF00651 | BTB/POZ domain | 161 | 266 | 1.3E-27 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/47049|m.13378 | UnnamedSample_HQ_transcript/47049 | Coverage 0.470 too low. | 65fb626b5653d7a1bf80885b155bad86 | 297 | Pfam | PF11571 | Mediator complex subunit 27 | 216 | 296 | 1.6E-20 | T | 22-09-2020 | IPR021627 | Mediator complex, subunit Med27 |
| UnnamedSample_HQ_transcript/95549|m.22029 | UnnamedSample_HQ_transcript/95549 | Coverage 0.874 too low. | 6502bc50e56caf6324216904ae281274 | 243 | Pfam | PF00642 | Zinc finger C-x8-C-x5-C-x3-H type (and similar) | 29 | 50 | 3.1E-5 | T | 22-09-2020 | IPR000571 | Zinc finger, CCCH-type |
| UnnamedSample_HQ_transcript/35769|m.10875 | UnnamedSample_HQ_transcript/35769 | Coverage 0.222 too low. | e6edc0dac81e94daffade017d4241354 | 537 | Pfam | PF00664 | ABC transporter transmembrane region | 3 | 246 | 6.2E-39 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/35769|m.10875 | UnnamedSample_HQ_transcript/35769 | Coverage 0.222 too low. | e6edc0dac81e94daffade017d4241354 | 537 | Pfam | PF00005 | ABC transporter | 316 | 463 | 1.1E-27 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/54238|m.14885 | UnnamedSample_HQ_transcript/54238 | Coverage 0.703 too low. | 856caabca79447ad73b50c53298137ec | 630 | Pfam | PF02359 | Cell division protein 48 (CDC48), N-terminal domain | 2 | 83 | 6.7E-11 | T | 22-09-2020 | IPR003338 | CDC48, N-terminal subdomain |
| UnnamedSample_HQ_transcript/54238|m.14885 | UnnamedSample_HQ_transcript/54238 | Coverage 0.703 too low. | 856caabca79447ad73b50c53298137ec | 630 | Pfam | PF17862 | AAA+ lid domain | 418 | 454 | 9.5E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/54238|m.14885 | UnnamedSample_HQ_transcript/54238 | Coverage 0.703 too low. | 856caabca79447ad73b50c53298137ec | 630 | Pfam | PF02933 | Cell division protein 48 (CDC48), domain 2 | 107 | 157 | 4.4E-5 | T | 22-09-2020 | IPR004201 | CDC48, domain 2 |
| UnnamedSample_HQ_transcript/54238|m.14885 | UnnamedSample_HQ_transcript/54238 | Coverage 0.703 too low. | 856caabca79447ad73b50c53298137ec | 630 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 251 | 391 | 6.6E-40 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/54238|m.14885 | UnnamedSample_HQ_transcript/54238 | Coverage 0.703 too low. | 856caabca79447ad73b50c53298137ec | 630 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 534 | 605 | 2.5E-8 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/19199|m.6634 | UnnamedSample_HQ_transcript/19199 | Coverage 0.757 too low. | 5ef220ab169f4c4b5e6e11f3c43186dd | 532 | Pfam | PF00571 | CBS domain | 275 | 321 | 1.0E-5 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/19199|m.6634 | UnnamedSample_HQ_transcript/19199 | Coverage 0.757 too low. | 5ef220ab169f4c4b5e6e11f3c43186dd | 532 | Pfam | PF00571 | CBS domain | 421 | 468 | 8.7E-10 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/19199|m.6634 | UnnamedSample_HQ_transcript/19199 | Coverage 0.757 too low. | 5ef220ab169f4c4b5e6e11f3c43186dd | 532 | Pfam | PF00571 | CBS domain | 348 | 394 | 5.2E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/88364|m.20992 | UnnamedSample_HQ_transcript/88364 | Coverage 0.920 too low. | 1516558a56c1bc21db1f10bbbaca6026 | 288 | Pfam | PF00135 | Carboxylesterase family | 1 | 280 | 1.9E-32 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/83244|m.20232 | UnnamedSample_HQ_transcript/83244 | Coverage 0.858 too low. | 1516558a56c1bc21db1f10bbbaca6026 | 288 | Pfam | PF00135 | Carboxylesterase family | 1 | 280 | 1.9E-32 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/60419|m.16148 | UnnamedSample_HQ_transcript/60419 | Coverage 0.738 too low. | 5541aa96d715c39ba781a9ddc13a285c | 347 | Pfam | PF08174 | Cell division protein anillin | 101 | 243 | 4.9E-45 | T | 22-09-2020 | IPR012966 | Anillin homology domain |
| UnnamedSample_HQ_transcript/93441|m.21724 | UnnamedSample_HQ_transcript/93441 | Coverage 0.645 too low. | 5abe0721bf8e0dd306c53947920ce0c4 | 303 | Pfam | PF12052 | Voltage gated calcium channel subunit beta domain 4Aa N terminal | 30 | 69 | 3.6E-17 | T | 22-09-2020 | IPR000584 | Voltage-dependent calcium channel, L-type, beta subunit |
| UnnamedSample_HQ_transcript/93441|m.21724 | UnnamedSample_HQ_transcript/93441 | Coverage 0.645 too low. | 5abe0721bf8e0dd306c53947920ce0c4 | 303 | Pfam | PF00625 | Guanylate kinase | 230 | 299 | 1.1E-10 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/73263|m.18520 | UnnamedSample_HQ_transcript/73263 | Coverage 0.743 too low. | 33adffcf3239df7e0376689d5d436283 | 321 | Pfam | PF01546 | Peptidase family M20/M25/M40 | 1 | 317 | 1.6E-37 | T | 22-09-2020 | IPR002933 | Peptidase M20 |
| UnnamedSample_HQ_transcript/73263|m.18520 | UnnamedSample_HQ_transcript/73263 | Coverage 0.743 too low. | 33adffcf3239df7e0376689d5d436283 | 321 | Pfam | PF07687 | Peptidase dimerisation domain | 108 | 218 | 3.3E-11 | T | 22-09-2020 | IPR011650 | Peptidase M20, dimerisation domain |
| UnnamedSample_HQ_transcript/48825|m.13764 | UnnamedSample_HQ_transcript/48825 | Coverage 0.960 too low. | f27c20dcaa5375d192a356f34d8052ca | 696 | Pfam | PF09088 | MIF4G like | 349 | 472 | 2.2E-30 | T | 22-09-2020 | IPR015172 | MIF4G-like, type 1 |
| UnnamedSample_HQ_transcript/48825|m.13764 | UnnamedSample_HQ_transcript/48825 | Coverage 0.960 too low. | f27c20dcaa5375d192a356f34d8052ca | 696 | Pfam | PF02854 | MIF4G domain | 45 | 237 | 2.9E-23 | T | 22-09-2020 | IPR003890 | MIF4G-like, type 3 |
| UnnamedSample_HQ_transcript/48825|m.13764 | UnnamedSample_HQ_transcript/48825 | Coverage 0.960 too low. | f27c20dcaa5375d192a356f34d8052ca | 696 | Pfam | PF09090 | MIF4G like | 487 | 689 | 4.4E-60 | T | 22-09-2020 | IPR015174 | MIF4G-like, type 2 |
| UnnamedSample_HQ_transcript/84106|m.20356 | UnnamedSample_HQ_transcript/84106 | Coverage 0.975 too low. | 91c368012ef6576b4e45c1fd426a8137 | 271 | Pfam | PF00112 | Papain family cysteine protease | 90 | 262 | 9.2E-32 | T | 22-09-2020 | IPR000668 | Peptidase C1A, papain C-terminal |
| UnnamedSample_HQ_transcript/84106|m.20356 | UnnamedSample_HQ_transcript/84106 | Coverage 0.975 too low. | 91c368012ef6576b4e45c1fd426a8137 | 271 | Pfam | PF08127 | Peptidase family C1 propeptide | 33 | 66 | 8.0E-13 | T | 22-09-2020 | IPR012599 | Peptidase C1A, propeptide |
| UnnamedSample_HQ_transcript/3496|m.1615 | UnnamedSample_HQ_transcript/3496 | Coverage 0.720 too low. | 3c55105003a325ff2054ae0b7545a9b9 | 1201 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 1108 | 1184 | 1.4E-4 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/3496|m.1615 | UnnamedSample_HQ_transcript/3496 | Coverage 0.720 too low. | 3c55105003a325ff2054ae0b7545a9b9 | 1201 | Pfam | PF00041 | Fibronectin type III domain | 349 | 433 | 2.7E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3496|m.1615 | UnnamedSample_HQ_transcript/3496 | Coverage 0.720 too low. | 3c55105003a325ff2054ae0b7545a9b9 | 1201 | Pfam | PF13637 | Ankyrin repeats (many copies) | 193 | 245 | 1.9E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF00028 | Cadherin domain | 1 | 80 | 3.2E-7 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF00028 | Cadherin domain | 418 | 501 | 8.1E-9 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF00028 | Cadherin domain | 535 | 622 | 2.8E-10 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF00028 | Cadherin domain | 209 | 286 | 8.0E-17 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF00028 | Cadherin domain | 316 | 401 | 5.5E-16 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF02210 | Laminin G domain | 952 | 1094 | 2.1E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/525|m.387 | UnnamedSample_HQ_transcript/525 | Coverage 0.519 too low. | e3aa83c954c8e28508fc05e8b2e36e54 | 1308 | Pfam | PF01049 | Cadherin cytoplasmic region | 1152 | 1289 | 8.8E-45 | T | 22-09-2020 | IPR000233 | Cadherin, cytoplasmic domain |
| UnnamedSample_HQ_transcript/43264|m.12548 | UnnamedSample_HQ_transcript/43264 | Coverage 0.955 too low. | 881b4a4b50f79a5f3022795360726d54 | 503 | Pfam | PF00856 | SET domain | 88 | 370 | 1.4E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/57572|m.15560 | UnnamedSample_HQ_transcript/57572 | Coverage 0.971 too low. | 881b4a4b50f79a5f3022795360726d54 | 503 | Pfam | PF00856 | SET domain | 88 | 370 | 1.4E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/51317|m.14312 | UnnamedSample_HQ_transcript/51317 | Coverage 0.975 too low. | 881b4a4b50f79a5f3022795360726d54 | 503 | Pfam | PF00856 | SET domain | 88 | 370 | 1.4E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/1682|m.930 | UnnamedSample_HQ_transcript/1682 | Coverage 0.374 too low. | fa461b7df985a463096a3d6878fba5d9 | 1769 | Pfam | PF18701 | Family of unknown function (DUF5641) | 1672 | 1764 | 2.2E-21 | T | 22-09-2020 | IPR040676 | Domain of unknown function DUF5641 |
| UnnamedSample_HQ_transcript/1682|m.930 | UnnamedSample_HQ_transcript/1682 | Coverage 0.374 too low. | fa461b7df985a463096a3d6878fba5d9 | 1769 | Pfam | PF03564 | Protein of unknown function (DUF1759) | 160 | 302 | 1.0E-14 | T | 22-09-2020 | IPR005312 | Protein of unknown function DUF1759 |
| UnnamedSample_HQ_transcript/1682|m.930 | UnnamedSample_HQ_transcript/1682 | Coverage 0.374 too low. | fa461b7df985a463096a3d6878fba5d9 | 1769 | Pfam | PF05380 | Pao retrotransposon peptidase | 1000 | 1159 | 2.1E-47 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/1682|m.930 | UnnamedSample_HQ_transcript/1682 | Coverage 0.374 too low. | fa461b7df985a463096a3d6878fba5d9 | 1769 | Pfam | PF05585 | Putative peptidase (DUF1758) | 500 | 642 | 3.0E-11 | T | 22-09-2020 | IPR008737 | Peptidase aspartic, putative |
| UnnamedSample_HQ_transcript/62185|m.16484 | UnnamedSample_HQ_transcript/62185 | Coverage 0.927 too low. | 12eb8ff777a1e6d61b474515b1bd8b3b | 442 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 430 | 2.4E-171 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/67529|m.17501 | UnnamedSample_HQ_transcript/67529 | Coverage 0.957 too low. | 12eb8ff777a1e6d61b474515b1bd8b3b | 442 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 430 | 2.4E-171 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/15999|m.5707 | UnnamedSample_HQ_transcript/15999 | Coverage 0.492 too low. | 12eb8ff777a1e6d61b474515b1bd8b3b | 442 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 430 | 2.4E-171 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/11211|m.4226 | UnnamedSample_HQ_transcript/11211 | Coverage 0.644 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/11211|m.4226 | UnnamedSample_HQ_transcript/11211 | Coverage 0.644 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18647|m.6485 | UnnamedSample_HQ_transcript/18647 | Identity 0.730 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/18647|m.6485 | UnnamedSample_HQ_transcript/18647 | Identity 0.730 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/30313|m.9546 | UnnamedSample_HQ_transcript/30313 | Identity 0.678 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/30313|m.9546 | UnnamedSample_HQ_transcript/30313 | Identity 0.678 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13400|m.4927 | UnnamedSample_HQ_transcript/13400 | Identity 0.771 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/13400|m.4927 | UnnamedSample_HQ_transcript/13400 | Identity 0.771 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/5562|m.2375 | UnnamedSample_HQ_transcript/5562 | Identity 0.730 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/5562|m.2375 | UnnamedSample_HQ_transcript/5562 | Identity 0.730 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/7183|m.2920 | UnnamedSample_HQ_transcript/7183 | Coverage 0.621 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/7183|m.2920 | UnnamedSample_HQ_transcript/7183 | Coverage 0.621 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14373|m.5222 | UnnamedSample_HQ_transcript/14373 | Identity 0.751 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/14373|m.5222 | UnnamedSample_HQ_transcript/14373 | Identity 0.751 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/17088|m.6035 | UnnamedSample_HQ_transcript/17088 | Identity 0.738 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/17088|m.6035 | UnnamedSample_HQ_transcript/17088 | Identity 0.738 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/25435|m.8330 | UnnamedSample_HQ_transcript/25435 | Identity 0.700 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/25435|m.8330 | UnnamedSample_HQ_transcript/25435 | Identity 0.700 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18750|m.6516 | UnnamedSample_HQ_transcript/18750 | Identity 0.741 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/18750|m.6516 | UnnamedSample_HQ_transcript/18750 | Identity 0.741 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/7759|m.3105 | UnnamedSample_HQ_transcript/7759 | Coverage 0.656 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/7759|m.3105 | UnnamedSample_HQ_transcript/7759 | Coverage 0.656 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/27814|m.8921 | UnnamedSample_HQ_transcript/27814 | Identity 0.663 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/27814|m.8921 | UnnamedSample_HQ_transcript/27814 | Identity 0.663 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/41763|m.12212 | UnnamedSample_HQ_transcript/41763 | Identity 0.632 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.1E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/41763|m.12212 | UnnamedSample_HQ_transcript/41763 | Identity 0.632 too low. | a16358ba65c886b74a38e8d335fadd21 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/85944|m.20641 | UnnamedSample_HQ_transcript/85944 | Coverage 0.944 too low. | 334b152b4b7f330448729cf1ba43c6a3 | 404 | Pfam | PF01223 | DNA/RNA non-specific endonuclease | 230 | 390 | 7.7E-19 | T | 22-09-2020 | IPR001604 | DNA/RNA non-specific endonuclease |
| UnnamedSample_HQ_transcript/821|m.552 | UnnamedSample_HQ_transcript/821 | Identity 0.822 too low. | 7cac853e75311cade28b97a0227a55c1 | 2043 | Pfam | PF06920 | Dock homology region 2 | 1502 | 2026 | 1.7E-208 | T | 22-09-2020 | IPR010703 | Dedicator of cytokinesis, C-terminal |
| UnnamedSample_HQ_transcript/821|m.552 | UnnamedSample_HQ_transcript/821 | Identity 0.822 too low. | 7cac853e75311cade28b97a0227a55c1 | 2043 | Pfam | PF14429 | C2 domain in Dock180 and Zizimin proteins | 575 | 751 | 6.5E-49 | T | 22-09-2020 | IPR027007 | DHR-1 domain |
| UnnamedSample_HQ_transcript/821|m.552 | UnnamedSample_HQ_transcript/821 | Identity 0.822 too low. | 7cac853e75311cade28b97a0227a55c1 | 2043 | Pfam | PF11878 | Domain of unknown function (DUF3398) | 50 | 161 | 2.5E-32 | T | 22-09-2020 | IPR021816 | Dedicator of cytokinesis C/D, N-terminal |
| UnnamedSample_HQ_transcript/1506|m.856 | UnnamedSample_HQ_transcript/1506 | Coverage 0.883 too low. | d56e9ecc4a3dc71160d64149140389c8 | 1251 | Pfam | PF17787 | PH domain | 12 | 139 | 2.4E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/1506|m.856 | UnnamedSample_HQ_transcript/1506 | Coverage 0.883 too low. | d56e9ecc4a3dc71160d64149140389c8 | 1251 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 8.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/1506|m.856 | UnnamedSample_HQ_transcript/1506 | Coverage 0.883 too low. | d56e9ecc4a3dc71160d64149140389c8 | 1251 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 2.1E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/1506|m.856 | UnnamedSample_HQ_transcript/1506 | Coverage 0.883 too low. | d56e9ecc4a3dc71160d64149140389c8 | 1251 | Pfam | PF08703 | PLC-beta C terminal | 1081 | 1242 | 9.1E-15 | T | 22-09-2020 | IPR014815 | Phospholipase C-beta, C-terminal domain |
| UnnamedSample_HQ_transcript/1506|m.856 | UnnamedSample_HQ_transcript/1506 | Coverage 0.883 too low. | d56e9ecc4a3dc71160d64149140389c8 | 1251 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 9.2E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/19717|m.6793 | UnnamedSample_HQ_transcript/19717 | Coverage 0.065 too low. | 90e7d7607f6f2934f5dde53b633e36a7 | 693 | Pfam | PF18124 | Kindlin-2 N-terminal domain | 9 | 92 | 6.4E-38 | T | 22-09-2020 | IPR040790 | Kindlin-2, N-terminal |
| UnnamedSample_HQ_transcript/19717|m.6793 | UnnamedSample_HQ_transcript/19717 | Coverage 0.065 too low. | 90e7d7607f6f2934f5dde53b633e36a7 | 693 | Pfam | PF00373 | FERM central domain | 301 | 587 | 6.0E-35 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/19717|m.6793 | UnnamedSample_HQ_transcript/19717 | Coverage 0.065 too low. | 90e7d7607f6f2934f5dde53b633e36a7 | 693 | Pfam | PF00169 | PH domain | 405 | 491 | 2.6E-7 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/4631|m.2047 | UnnamedSample_HQ_transcript/4631 | Coverage 0.741 too low. | 18dcb450cf519292710640873c98229e | 981 | Pfam | PF02373 | JmjC domain, hydroxylase | 716 | 824 | 3.1E-29 | T | 22-09-2020 | IPR003347 | JmjC domain |
| UnnamedSample_HQ_transcript/5763|m.2448 | UnnamedSample_HQ_transcript/5763 | Coverage 0.727 too low. | 18dcb450cf519292710640873c98229e | 981 | Pfam | PF02373 | JmjC domain, hydroxylase | 716 | 824 | 3.1E-29 | T | 22-09-2020 | IPR003347 | JmjC domain |
| UnnamedSample_HQ_transcript/5062|m.2218 | UnnamedSample_HQ_transcript/5062 | Coverage 0.735 too low. | 18dcb450cf519292710640873c98229e | 981 | Pfam | PF02373 | JmjC domain, hydroxylase | 716 | 824 | 3.1E-29 | T | 22-09-2020 | IPR003347 | JmjC domain |
| UnnamedSample_HQ_transcript/13924|m.5090 | UnnamedSample_HQ_transcript/13924 | Coverage 0.722 too low. | 4cb677f564d16882bf5a0e69122e0944 | 1078 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 19 | 115 | 6.6E-11 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/13924|m.5090 | UnnamedSample_HQ_transcript/13924 | Coverage 0.722 too low. | 4cb677f564d16882bf5a0e69122e0944 | 1078 | Pfam | PF00612 | IQ calmodulin-binding motif | 936 | 953 | 0.035 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/13924|m.5090 | UnnamedSample_HQ_transcript/13924 | Coverage 0.722 too low. | 4cb677f564d16882bf5a0e69122e0944 | 1078 | Pfam | PF00612 | IQ calmodulin-binding motif | 963 | 982 | 0.18 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/13924|m.5090 | UnnamedSample_HQ_transcript/13924 | Coverage 0.722 too low. | 4cb677f564d16882bf5a0e69122e0944 | 1078 | Pfam | PF00612 | IQ calmodulin-binding motif | 988 | 1005 | 0.013 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/13924|m.5090 | UnnamedSample_HQ_transcript/13924 | Coverage 0.722 too low. | 4cb677f564d16882bf5a0e69122e0944 | 1078 | Pfam | PF00063 | Myosin head (motor domain) | 150 | 897 | 2.3E-221 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/116077|m.24499 | UnnamedSample_HQ_transcript/116077 | Coverage 0.974 too low. | a83379781ff8b78c1619e853f34b86f3 | 134 | Pfam | PF01434 | Peptidase family M41 | 1 | 78 | 1.0E-15 | T | 22-09-2020 | IPR000642 | Peptidase M41 |
| UnnamedSample_HQ_transcript/104427|m.23158 | UnnamedSample_HQ_transcript/104427 | Coverage 0.706 too low. | 208ad70aa3eddb435490f36c1e62bd9f | 180 | Pfam | PF00041 | Fibronectin type III domain | 90 | 151 | 8.3E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/34389|m.10572 | UnnamedSample_HQ_transcript/34389 | Coverage 0.851 too low. | bd2430e7a8c3d4fcd18dd259c7c486e7 | 391 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 227 | 335 | 5.2E-32 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/34389|m.10572 | UnnamedSample_HQ_transcript/34389 | Coverage 0.851 too low. | bd2430e7a8c3d4fcd18dd259c7c486e7 | 391 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 3 | 211 | 6.1E-79 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/20802|m.7092 | UnnamedSample_HQ_transcript/20802 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20802|m.7092 | UnnamedSample_HQ_transcript/20802 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20802|m.7092 | UnnamedSample_HQ_transcript/20802 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16065|m.5732 | UnnamedSample_HQ_transcript/16065 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16065|m.5732 | UnnamedSample_HQ_transcript/16065 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16065|m.5732 | UnnamedSample_HQ_transcript/16065 | Coverage 0.948 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16784|m.5939 | UnnamedSample_HQ_transcript/16784 | Identity 0.909 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16784|m.5939 | UnnamedSample_HQ_transcript/16784 | Identity 0.909 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16784|m.5939 | UnnamedSample_HQ_transcript/16784 | Identity 0.909 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24401|m.8047 | UnnamedSample_HQ_transcript/24401 | Identity 0.918 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24401|m.8047 | UnnamedSample_HQ_transcript/24401 | Identity 0.918 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24401|m.8047 | UnnamedSample_HQ_transcript/24401 | Identity 0.918 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22966|m.7680 | UnnamedSample_HQ_transcript/22966 | Identity 0.904 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22966|m.7680 | UnnamedSample_HQ_transcript/22966 | Identity 0.904 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22966|m.7680 | UnnamedSample_HQ_transcript/22966 | Identity 0.904 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/12929|m.4797 | UnnamedSample_HQ_transcript/12929 | Identity 0.913 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/12929|m.4797 | UnnamedSample_HQ_transcript/12929 | Identity 0.913 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/12929|m.4797 | UnnamedSample_HQ_transcript/12929 | Identity 0.913 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22929|m.7672 | UnnamedSample_HQ_transcript/22929 | Coverage 0.945 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22929|m.7672 | UnnamedSample_HQ_transcript/22929 | Coverage 0.945 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22929|m.7672 | UnnamedSample_HQ_transcript/22929 | Coverage 0.945 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22303|m.7515 | UnnamedSample_HQ_transcript/22303 | Identity 0.921 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22303|m.7515 | UnnamedSample_HQ_transcript/22303 | Identity 0.921 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/22303|m.7515 | UnnamedSample_HQ_transcript/22303 | Identity 0.921 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18063|m.6322 | UnnamedSample_HQ_transcript/18063 | Coverage 0.950 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18063|m.6322 | UnnamedSample_HQ_transcript/18063 | Coverage 0.950 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18063|m.6322 | UnnamedSample_HQ_transcript/18063 | Coverage 0.950 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20175|m.6914 | UnnamedSample_HQ_transcript/20175 | Identity 0.905 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20175|m.6914 | UnnamedSample_HQ_transcript/20175 | Identity 0.905 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/20175|m.6914 | UnnamedSample_HQ_transcript/20175 | Identity 0.905 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/29603|m.9381 | UnnamedSample_HQ_transcript/29603 | Coverage 0.940 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/29603|m.9381 | UnnamedSample_HQ_transcript/29603 | Coverage 0.940 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 791 | 871 | 5.9E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/29603|m.9381 | UnnamedSample_HQ_transcript/29603 | Coverage 0.940 too low. | 7c355fac5d4e4e2602311a7aadb0878f | 920 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/68373|m.17650 | UnnamedSample_HQ_transcript/68373 | Coverage 0.976 too low. | 56f45f9c86d3d99b1fcbe3514ab279c4 | 471 | Pfam | PF00067 | Cytochrome P450 | 37 | 423 | 1.8E-57 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/93741|m.21775 | UnnamedSample_HQ_transcript/93741 | Coverage 0.970 too low. | c76e9a0c8ec4df61205424d82853389e | 384 | Pfam | PF00992 | Troponin | 152 | 228 | 2.6E-10 | T | 22-09-2020 | IPR001978 | Troponin |
| UnnamedSample_HQ_transcript/36191|m.10979 | UnnamedSample_HQ_transcript/36191 | Identity 0.922 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00069 | Protein kinase domain | 212 | 505 | 3.8E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/36191|m.10979 | UnnamedSample_HQ_transcript/36191 | Identity 0.922 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00531 | Death domain | 27 | 101 | 1.1E-6 | T | 22-09-2020 | IPR000488 | Death domain |
| UnnamedSample_HQ_transcript/35535|m.10828 | UnnamedSample_HQ_transcript/35535 | Identity 0.922 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00069 | Protein kinase domain | 212 | 505 | 3.8E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/35535|m.10828 | UnnamedSample_HQ_transcript/35535 | Identity 0.922 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00531 | Death domain | 27 | 101 | 1.1E-6 | T | 22-09-2020 | IPR000488 | Death domain |
| UnnamedSample_HQ_transcript/39899|m.11829 | UnnamedSample_HQ_transcript/39899 | Identity 0.839 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00069 | Protein kinase domain | 212 | 505 | 3.8E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/39899|m.11829 | UnnamedSample_HQ_transcript/39899 | Identity 0.839 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00531 | Death domain | 27 | 101 | 1.1E-6 | T | 22-09-2020 | IPR000488 | Death domain |
| UnnamedSample_HQ_transcript/32777|m.10157 | UnnamedSample_HQ_transcript/32777 | Identity 0.925 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00069 | Protein kinase domain | 212 | 505 | 3.8E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/32777|m.10157 | UnnamedSample_HQ_transcript/32777 | Identity 0.925 too low. | 6e98a4bbd38a814d234c51827ffdb140 | 655 | Pfam | PF00531 | Death domain | 27 | 101 | 1.1E-6 | T | 22-09-2020 | IPR000488 | Death domain |
| UnnamedSample_HQ_transcript/85476|m.20568 | UnnamedSample_HQ_transcript/85476 | Identity 0.671 too low. | 7d273be1e84b2a86a4e874658296c0bc | 362 | Pfam | PF18382 | Formin N-terminal GTPase-binding domain | 4 | 102 | 1.3E-41 | T | 22-09-2020 | IPR041387 | FHOD1, N-terminal GTPase-binding domain |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 18 | 39 | 3.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 75 | 97 | 1.1E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 166 | 187 | 0.0034 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 193 | 212 | 0.0025 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 104 | 126 | 0.0029 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/51750|m.14397 | UnnamedSample_HQ_transcript/51750 | Coverage 0.771 too low. | c40a9a54d7c6aaf5bb11bfa9fb0a451a | 531 | Pfam | PF00096 | Zinc finger, C2H2 type | 132 | 154 | 2.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/18402|m.6422 | UnnamedSample_HQ_transcript/18402 | Identity 0.746 too low. | a722a903a166c6e1f09962f83ebfcc93 | 262 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 2 | 33 | 1.6E-4 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/78248|m.19414 | UnnamedSample_HQ_transcript/78248 | Identity 0.873 too low. | 6ff124a78b4422fba56ea0bd4bb62933 | 315 | Pfam | PF03022 | Major royal jelly protein | 16 | 283 | 4.8E-57 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/94427|m.21862 | UnnamedSample_HQ_transcript/94427 | Coverage 0.978 too low. | 80da773b343459d47c303884116f954c | 313 | Pfam | PF11715 | Nucleoporin Nup120/160 | 47 | 274 | 1.0E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21569|m.7300 | UnnamedSample_HQ_transcript/21569 | Coverage 0.166 too low. | e453a6a01f0d476f096efda1bd7b75a3 | 592 | Pfam | PF00028 | Cadherin domain | 418 | 508 | 2.7E-9 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/21569|m.7300 | UnnamedSample_HQ_transcript/21569 | Coverage 0.166 too low. | e453a6a01f0d476f096efda1bd7b75a3 | 592 | Pfam | PF00028 | Cadherin domain | 1 | 80 | 1.1E-7 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/21569|m.7300 | UnnamedSample_HQ_transcript/21569 | Coverage 0.166 too low. | e453a6a01f0d476f096efda1bd7b75a3 | 592 | Pfam | PF00028 | Cadherin domain | 209 | 286 | 2.7E-17 | T | 22-09-2020 | IPR002126 | Cadherin-like |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
